微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.65% | 68.37% | -57.14% | 65/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.85% | 97.44% | 55.87% | 67/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.47% | 1.65% | 15.42% | 94/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.14% | 75.41% | 118.37% | 79/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.98% | 24.05% | -49.74% | 94/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.95% | -87.42% | -19.75% | 89/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.43% | -86.22% | 99.18% | 98/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.22% | -86.77% | 54.43% | 98/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.79% | -86.09% | -94.9% | 99/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 15.5% | -28.96% | -12.13% | 18/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 17.64% | 7.1% | 91.32% | 5/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.22% | -12.94% | 62.32% | 14/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.68% | 53.1% | -73.97% | 9/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 21.82% | 70.87% | 32.48% | 9/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 16.47% | 130.35% | 55.52% | 9/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.59% | 2% | 185.44% | 14/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.71% | 827.5% | -70.95% | 28/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 12.77% | 55.35% | 78.6% | 38/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.15% | 2% | 1687.5% | 56/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 0.4% | 2% | -95.13% | 76/158 | 2.19% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 8.22% | 0.61% | 0.61% | 68/158 | 2.53% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 8.17% | -46.32% | -46.32% | 63/158 | 6.99% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-12-31 | 15.22% | 2% | 2% | 24/158 | 9.61% | 奥赛康 | 35% | 行业排名> |